The Global Cancer Biomarker Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
Scope of the Report:
In terms of applications, diagnostics accounted for major share of the global cancer biomarkers market in 2017.
The worldwide market for Cancer Biomarker is expected to grow at a CAGR of roughly 12.2% over the next five years, will reach 23100 million US$ in 2024, from 11600 million US$ in 2019.
This report focuses on the Cancer Biomarker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Table of Contents
1 Market Overview
1.1 Cancer Biomarker Introduction
1.2 Market Analysis by Type
1.2.1 Protein Biomarker
1.2.2 Genetic Biomarker
1.3 Market Analysis by Applications
1.3.1 Diagnostics
1.3.2 Research
1.3.3 Prognostics
1.3.4 Risk Assessment
1.3.5 Other Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Business Overview
2.1.2 Cancer Biomarker Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bio-Rad Laboratories
2.2.1 Business Overview
2.2.2 Cancer Biomarker Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 Cancer Biomarker Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Qiagen
2.4.1 Business Overview
2.4.2 Cancer Biomarker Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qiagen Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Illumina
2.5.1 Business Overview
2.5.2 Cancer Biomarker Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 GE Healthcare
2.6.1 Business Overview
2.6.2 Cancer Biomarker Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Healthcare Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Agilent Technologies
2.7.1 Business Overview
2.7.2 Cancer Biomarker Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Agilent Technologies Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biomérieux SA
2.8.1 Business Overview
2.8.2 Cancer Biomarker Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomérieux SA Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Merck & Co.
2.9.1 Business Overview
2.9.2 Cancer Biomarker Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck & Co. Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Abbott Laboratories
2.10.1 Business Overview
2.10.2 Cancer Biomarker Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abbott Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Becton, Dickinson and Company
2.11.1 Business Overview
2.11.2 Cancer Biomarker Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Danaher Corporation
2.12.1 Business Overview
2.12.2 Cancer Biomarker Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Danaher Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Myriad Genetics
2.13.1 Business Overview
2.13.2 Cancer Biomarker Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Myriad Genetics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Sysmex Corporation
2.14.1 Business Overview
2.14.2 Cancer Biomarker Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sysmex Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Hologic
2.15.1 Business Overview
2.15.2 Cancer Biomarker Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hologic Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Quest Diagnostics
2.16.1 Business Overview
2.16.2 Cancer Biomarker Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Quest Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Biomarker Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Cancer Biomarker Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Cancer Biomarker Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Biomarker Manufacturer Market Share in 2018
3.3.2 Top 6 Cancer Biomarker Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Cancer Biomarker Market Analysis by Regions
4.1 Global Cancer Biomarker Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Biomarker Sales and Market Share by Regions (2014-2019)
4.1.2 Global Cancer Biomarker Revenue and Market Share by Regions (2014-2019)
4.2 North America Cancer Biomarker Sales and Growth Rate (2014-2019)
4.3 Europe Cancer Biomarker Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Biomarker Sales and Growth Rate (2014-2019)
4.5 South America Cancer Biomarker Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Biomarker Sales and Growth Rate (2014-2019)
5 North America Cancer Biomarker by Country
5.1 North America Cancer Biomarker Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Biomarker Sales and Market Share by Country (2014-2019)
5.1.2 North America Cancer Biomarker Revenue and Market Share by Country (2014-2019)
5.2 United States Cancer Biomarker Sales and Growth Rate (2014-2019)
5.3 Canada Cancer Biomarker Sales and Growth Rate (2014-2019)
5.4 Mexico Cancer Biomarker Sales and Growth Rate (2014-2019)
6 Europe Cancer Biomarker by Country
6.1 Europe Cancer Biomarker Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Biomarker Sales and Market Share by Country (2014-2019)
6.1.2 Europe Cancer Biomarker Revenue and Market Share by Country (2014-2019)
6.2 Germany Cancer Biomarker Sales and Growth Rate (2014-2019)
6.3 UK Cancer Biomarker Sales and Growth Rate (2014-2019)
6.4 France Cancer Biomarker Sales and Growth Rate (2014-2019)
6.5 Russia Cancer Biomarker Sales and Growth Rate (2014-2019)
6.6 Italy Cancer Biomarker Sales and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Biomarker by Country
7.1 Asia-Pacific Cancer Biomarker Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Cancer Biomarker Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Cancer Biomarker Revenue and Market Share by Country (2014-2019)
7.2 China Cancer Biomarker Sales and Growth Rate (2014-2019)
7.3 Japan Cancer Biomarker Sales and Growth Rate (2014-2019)
7.4 Korea Cancer Biomarker Sales and Growth Rate (2014-2019)
7.5 India Cancer Biomarker Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Biomarker Sales and Growth Rate (2014-2019)
8 South America Cancer Biomarker by Country
8.1 South America Cancer Biomarker Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Biomarker Sales and Market Share by Country (2014-2019)
8.1.2 South America Cancer Biomarker Revenue and Market Share by Country (2014-2019)
8.2 Brazil Cancer Biomarker Sales and Growth Rate (2014-2019)
8.3 Argentina Cancer Biomarker Sales and Growth Rate (2014-2019)
8.4 Colombia Cancer Biomarker Sales and Growth Rate (2014-2019)
9 Middle East and Africa Cancer Biomarker by Countries
9.1 Middle East and Africa Cancer Biomarker Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Cancer Biomarker Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Cancer Biomarker Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Cancer Biomarker Sales and Growth Rate (2014-2019)
9.3 Turkey Cancer Biomarker Sales and Growth Rate (2014-2019)
9.4 Egypt Cancer Biomarker Sales and Growth Rate (2014-2019)
9.5 Nigeria Cancer Biomarker Sales and Growth Rate (2014-2019)
9.6 South Africa Cancer Biomarker Sales and Growth Rate (2014-2019)
10 Global Cancer Biomarker Market Segment by Type
10.1 Global Cancer Biomarker Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Cancer Biomarker Sales and Market Share by Type (2014-2019)
10.1.2 Global Cancer Biomarker Revenue and Market Share by Type (2014-2019)
10.2 Protein Biomarker Sales Growth and Price
10.2.1 Global Protein Biomarker Sales Growth (2014-2019)
10.2.2 Global Protein Biomarker Price (2014-2019)
10.3 Genetic Biomarker Sales Growth and Price
10.3.1 Global Genetic Biomarker Sales Growth (2014-2019)
10.3.2 Global Genetic Biomarker Price (2014-2019)
11 Global Cancer Biomarker Market Segment by Application
11.1 Global Cancer Biomarker Sales Market Share by Application (2014-2019)
11.2 Diagnostics Sales Growth (2014-2019)
11.3 Research Sales Growth (2014-2019)
11.4 Prognostics Sales Growth (2014-2019)
11.5 Risk Assessment Sales Growth (2014-2019)
11.6 Other Applications Sales Growth (2014-2019)
12 Cancer Biomarker Market Forecast (2019-2024)
12.1 Global Cancer Biomarker Sales, Revenue and Growth Rate (2019-2024)
12.2 Cancer Biomarker Market Forecast by Regions (2019-2024)
12.2.1 North America Cancer Biomarker Market Forecast (2019-2024)
12.2.2 Europe Cancer Biomarker Market Forecast (2019-2024)
12.2.3 Asia-Pacific Cancer Biomarker Market Forecast (2019-2024)
12.2.4 South America Cancer Biomarker Market Forecast (2019-2024)
12.2.5 Middle East and Africa Cancer Biomarker Market Forecast (2019-2024)
12.3 Cancer Biomarker Market Forecast by Type (2019-2024)
12.3.1 Global Cancer Biomarker Sales Forecast by Type (2019-2024)
12.3.2 Global Cancer Biomarker Market Share Forecast by Type (2019-2024)
12.4 Cancer Biomarker Market Forecast by Application (2019-2024)
12.4.1 Global Cancer Biomarker Sales Forecast by Application (2019-2024)
12.4.2 Global Cancer Biomarker Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
The report on the Global Air Filter Masks Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global CT Machine Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The report on the Global Bead Wire Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Nasopharyngoscope Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Digital Radiography Systems Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Dental Extraction Forceps Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Endoscopic Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The report on the Global Bronchoscope Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global 3D Printing Medical Devices Market Research Report provides a detailed market overview along with the analysis of industry’s gross read more..
The report on the Global Cystoscope Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..